Does Acupuncture Work for Eye Disease?
The Evidence, Honestly

Patients often ask this question after standard treatmenthas stabilized one part of the disease but has not restored function, or after they have been told that no additional disease-modifying treatment is available. That makes the question emotionally charged. A responsible answer must separate three things: whether acupuncture can affect physiology, whether it can improve a symptom or test result, and whether it has proven that it changes the long-term course of a specific eye disease.

What acupuncture is - and what it is not

Acupuncture uses sterile, single-use needles placed at selected points on the body, sometimes with manual stimulation or a small electrical current. Traditional Chinese Medicine describes treatment through patterns and meridians. Modern research also investigates sensory-nerve signaling, autonomic regulation, connective-tissue effects, endogenous pain modulation, local blood flow, inflammatory mediators and brain responses.

These explanations are not mutually exclusive, and the mechanism is not fully understood. NCCIH notes that acupuncture effects may include specific nervous-system and tissue effects as well as nonspecific effects related to expectation, context and the therapeutic encounter. The fact that a treatment produces a biological response does not prove that it treats an eye disease.

What counts as convincing evidence?

Acupuncture trials are difficult to design. “Sham” acupuncture may not be biologically inert. Blinding the practitioner is generally impossible. Point selection, treatment frequency and practitioner technique vary. Small studies can produce unstable results, and positive studies are more likely to be published. For chronic eye disease, a brief improvement in acuity, circulation measurement or symptom score is not the same as slower structural progression over years.

The most useful evidence hierarchy is: replicated randomized trials with credible controls and objective outcomes; systematic reviews that account for study quality; prospective cohorts; small uncontrolled studies; mechanistic or laboratory studies; and practitioner experience. Each level can generate a hypothesis, but they do not carry the same weight.

Dry eye disease: the strongest current eye-related evidence base

Dry eye is a multifactorial ocular-surface disorder involving tear-film instability, inflammation, neurosensory abnormalities and eyelid-gland dysfunction. Acupuncture has been compared with artificial tears, sham procedures and combined treatment in multiple trials. Some systematic reviews and randomized studies report improvements in symptoms, tear breakup time, Schirmer testing or ocular-surface measures, particularly when acupuncture is added to artificial tears.

The limitations are important: protocols vary; some trials are small or unblinded; the clinical importance of test changes is not always clear; and dry eye has several subtypes that respond differently. Acupuncture may be a reasonable adjunct for selected patients with persistent symptoms, but it should not replace evaluation for meibomian gland dysfunction, Sjögren’s disease, medication toxicity, corneal neuropathic pain, infection or other causes.

Glaucoma: insufficient evidence for disease control

The best-established way to reduce glaucoma risk is lowering intraocular pressure and monitoring the optic nerve and visual field. Cochrane reviews have found the acupuncture evidence for glaucoma inadequate for conclusions about effectiveness and safety. Existing trials have generally been small, short, methodologically weak or focused on temporary changes rather than long-term visual-field preservation.

Acupuncture should never be represented as a substitute for pressure-lowering drops, laser or surgery. At most, it can be investigated as an adjunct aimed at symptoms, stress regulation, adherence, quality of life or proposed vascular and neural-support mechanisms. Any claim that it “stops glaucoma” requires evidence that does not currently exist.

Age-related macular degeneration: signals, but low certainty

Systematic reviews of acupuncture for AMD have reported favorable pooled results in visual acuity or composite “clinical effectiveness” outcomes. However, many included studies have small samples, variable diagnostic stages, inconsistent control groups, unclear masking and outcomes that are not standard in international retinal trials. Publication bias and study quality reduce confidence in the pooled result.

For wet AMD, anti-VEGF therapy remains essential. Acupuncture should not delay injections or be used to extend an injection interval without the retina specialist’s direction. For dry AMD, evidence-based risk reduction, AREDS2 when indicated, smoking cessation, monitoring and low-vision support remain central. Acupuncture can be discussed only as an adjunct with uncertain disease-modifying benefit.

Retinitis pigmentosa, Stargardt disease and other inherited retinal diseases

Small observational studies and case series have explored acupuncture in inherited retinal disease, but there is no robust evidence that it corrects a genetic defect, regenerates photoreceptors or reliably slows degeneration. Subjective improvement, short-term functional change and test-learning effects must be distinguished from altered natural history. Patients should prioritize genetic testing, inherited-retinal-disease specialist care, clinical-trial screening and low-vision rehabilitation.

Optic neuropathy, ocular blood flow and neuroprotection claims

Researchers have measured short-term changes in blood flow, autonomic activity and visual function after acupuncture. Those studies may help explain possible physiological effects, but they do not establish regeneration or long-term protection. An ischemic optic neuropathy, sudden retinal vascular event or acute neurologic symptom requires urgent conventional evaluation.

How Netra Eye Institute should use the evidence

Netra Eye Institute uses acupuncture as just one component of NRT, not as a standalone treatment protocol. The clinical approach is to define its purpose for each patient. Examples may include supporting dry-eye symptom control, stress and autonomic regulation, treatment adherence, general well-being, or an investigational attempt to influence circulation and neural resilience while standard care continues.

The treatment plan will state the evidence level, number and frequency of sessions, safety considerations, expected time frame, and outcome measures. For progressive disease, objective ophthalmic testing will be performed by or coordinated with the patient’s eye doctor. If no measurable benefit is observed, the plan will be reconsidered rather than continued indefinitely without objective justification.

Safety: usually low risk, but not risk free

When performed by a properly trained, licensed practitioner using sterile single-use needles, acupuncture is generally considered low risk. Common effects include temporary soreness, bruising, light-headedness or fatigue. Rare but serious complications include infection, organ puncture and nerve injury. Extra caution is required with anticoagulants, bleeding disorders, pregnancy, implanted electrical devices when electroacupuncture is used, severe frailty, infection and inability to communicate symptoms.

Eye-area safety
NRT acupuncture treatments does not involve ANY needles inserted into the globe or around the eye (periocular). Periocular techniques poses a significantly higher risk to patients and if you were subjected to such treatments from another practitioner you should report severe pain, persistent redness, sudden vision change, flashes, floaters or neurologic symptoms immediately to your ophthalmologist.

How to recognize an evidence-informed practitioner

An evidence-informed practitioner combines clinical experience with the best available research, patient safety and coordinated medical care. In integrative eye care, this means understanding the patient’s confirmed ophthalmic diagnosis, respecting the role of established treatments and being transparent about what an adjunctive therapy can and cannot reasonably achieve.

The following signs can help patients distinguish responsible, evidence-informed care from exaggerated or unsupported claims.

1. They ask for your confirmed ophthalmic diagnosis and current treatment plan.
   ‍They review relevant eye examinations, imaging, visual-field testing, medications, injections, previous procedures and specialist recommendations before proposing adjunctive care.
2. They work alongside your ophthalmologist rather than attempting to replace them.
   ‍They do not advise you to discontinue prescribed eye drops, injections, laser procedures, surgery or specialist follow-up without consultation with the treating eye doctor.
3. They distinguish symptom improvement from disease modification.
   ‍Feeling more comfortable, seeing more clearly temporarily or experiencing reduced eye strain does not necessarily mean that the underlying disease has stabilized or improved.
4. They make claims that are proportionate to the available evidence.
   ‍They avoid promising cures, guaranteed vision restoration or reversal of permanent retinal or optic-nerve damage.
5. They disclose the strength and limitations of the evidence.
   They clearly explain when support comes from established clinical research, small preliminary studies, indirect evidence, laboratory findings or traditional clinical experience.
6. They explain how the proposed therapy relates to the patient’s condition.
   ‍The rationale may involve symptom control, stress regulation, ocular-surface support, treatment adherence, general well-being or an investigational attempt to support physiological resilience while standard care continues.
7. They establish realistic and measurable treatment goals.
   ‍Depending on the condition, goals may include changes in symptoms, visual function, treatment tolerance, quality of life or objective ophthalmic findings.
8. They define a treatment period and review point.
   They recommend a reasonable number and frequency of sessions, explain when progress will be evaluated and reconsider the plan when meaningful benefit is not observed.
9. They establish realistic and measurable treatment goals.
   ‍Depending on the condition, goals may include changes in symptoms, visual function, treatment tolerance, quality of life or objective ophthalmic findings.
10. They use objective testing when disease progression is a concern.
    For glaucoma, retinal disease, optic neuropathy and other chronic conditions, they encourage monitoring through appropriate examinations such as OCT, visual-field testing, retinal imaging, intraocular-pressure measurement or other testing performed by the patient’s eye doctor.
11. They follow appropriate infection-control and safety procedures.
    When acupuncture is used, they use sterile, single-use needles, maintain a clean clinical environment and explain potential risks, contraindications and adverse effects.
12. They screen for contraindications and interactions.
    They ask about medications, anticoagulants, pregnancy, allergies, systemic illnesses, recent surgery and other factors that may affect treatment safety.
13. They document the treatment plan and clinical response.
    Responsible practitioners maintain records of the therapeutic rationale, interventions provided, patient-reported changes, adverse reactions and follow-up recommendations.
14. They encourage informed decision-making.
    They discuss potential benefits, uncertainties, risks, alternatives, treatment burden and cost before asking the patient to proceed.
15. They avoid pressure-based sales practices.
    They do not use fear, urgency or unrealistic claims to sell unlimited packages, expensive supplements or prolonged treatment without periodic clinical reassessment.
16. They recognize when adjunctive care is inappropriate or insufficient.
    They recognize when adjunctive care is inappropriate or insufficient.They refer the patient back to an ophthalmologist or another medical professional when the condition requires diagnostic clarification, procedural treatment or closer medical monitoring.
17. They recognize ocular and neurological emergencies.
    They recommend immediate medical evaluation for symptoms suggesting retinal detachment, acute angle-closure glaucoma, severe infection, vascular occlusion, stroke or another urgent condition.
18. They welcome communication with the patient’s healthcare team.
    With the patient’s permission, they are willing to coordinate with ophthalmologists, optometrists, primary-care clinicians and other treating professionals.
19. They are willing to stop or modify treatment.
    When the intervention is ineffective, poorly tolerated or no longer clinically appropriate, they revise or discontinue the plan rather than continuing indefinitely on belief alone.

Frequently Asked Questions

Selected References for Scientific Support

• National Center for Complementary and Integrative Health. Acupuncture: Effectiveness and Safety. Source
• Wang Y, et al. Effectiveness of acupuncture combined with artificial tears for dry eye disease. 2024. Source
• Law SK, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev. 2020. Source
• Sun W, et al. Effects of acupuncture on age-related macular degeneration: systematic review and meta-analysis. 2023. Source
• Chen KY, et al. Acupuncture as a therapeutic strategy for degenerative eye diseases. 2025. Source